Reasearch progress in health economic evaluation of colorectal cancer screening in China.
- Author:
Huiyao HUANG
1
;
Jufang SHI
2
;
Email: SHIJF@CICAMS.AC.CN.
;
Min DAI
1
Author Information
1. Office for Cancer Screening Program in Urban China National Cancer Center of China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China.
2. Office for Cancer Screening Program in Urban China National Cancer Center of China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China
- Publication Type:Journal Article
- MeSH:
China;
Colonoscopy;
Colorectal Neoplasms;
diagnosis;
Cost-Benefit Analysis;
Early Detection of Cancer;
economics;
Humans;
Occult Blood;
Risk Factors;
Surveys and Questionnaires
- From:
Chinese Journal of Preventive Medicine
2015;49(8):747-751
- CountryChina
- Language:Chinese
-
Abstract:
Burden of colorectal cancer is rising in China. More attention and financial input have been paid to it by central government that colorectal cancer screening program has been carried out recently in many areas in China. Diversity of screening strategies and limited health resources render selecting the best strategy in a population-wide program a challenging task that economy was also required to be considered except safety and efficacy. To provide a reference for the subsequent further economic evaluation, here we reviewed the evidence available on the economic evaluation of colorectal cancer screening in China. Meanwhile, information related to screening strategies, participation and mid-term efficacy of screening, information and results on economic evaluation were extracted and summarized. Three of the four studies finally included evaluated strategies combining immunochemical fecel occult blood test (iFOBT) with high-risk factor questionnaire as initial screening, colonoscopy as diagnostic screening. There was a consensus regarding the efficacy and effectiveness of screening compared to no screening. Whereas the lack and poor comparability between studies, multi-perspective and multi-phase economic evaluation of colorectal cancer screening is needed, relying on current population-based screening program to conduct a comprehensive cost accounting.
